Significance of viral status on prognosis after resection of hepatitis B virus related hepatocellular carcinoma

Journal of Hepatology

Volumn 47, Issue 5, 2007, Pages 630-631

  Poon, Ronnie T P ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; LAMIVUDINE;

CANCER SURGERY; CANCER SURVIVAL; EDITORIAL; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; LIVER CELL CARCINOMA; LIVER RESECTION; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SEROCONVERSION; TUMOR RECURRENCE; VIRUS REPLICATION;

CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HUMANS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; VIRAL LOAD;

EID: 34848852674     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.08.007     Document Type: Editorial

References (14)

1. Poon R.T., Fan S.T., Lo C.M., Ng I.O.L., Liu C.L., Lam C.M., et al. Improving survival results after resection of hepatocellular carcinoma A prospective study of 377 patients. Ann Surg 234 (2001) 63-70
2. Poon R.T., Fan S.T., and Wong J. Risk factors, prevention and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232 (2000) 10-24
3. Sun H.-C., Zhang W., Qin L.-X., Zhang B.-H., Ye Q.-H., Wang L., et al. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. J Hepatol 47 (2007) 684-690
4. Kubo S., Hirohashi K., Yamazaki O., Matsuyama M., Tanaka H., Horii K., et al. Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B. World J Surg 26 (2002) 555-560
5. Chen J.H., Chau G.Y., Lui W.Y., Tsay S.H., King K.L., Loong C.C., et al. Surgical results in patients with hepatitis B-related hepatocellular carcinoma and positive hepatitis B early antigen. World J Surg 24 (2000) 383-388
6. Yang H.I., Lu S.N., Liaw Y.F., You S.L., Sun C.A., Wang U.Y., et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 347 (2002) 168-174
7. Ueno S., Tanabe G., Yoshida A., Yoshidome S., Takao S., Aikou T., et al. Postoperative prediction of and strategy for metastatic recurrent hepatocellular carcinoma according to histologic activity of hepatitis. Cancer 86 (1999) 248-254
8. Lin S.M., Yu M.L., Lee C.M., Chien R.N., Sheen I.S., Chu C.M., et al. Interferon therapy in HBeAg positive chronic hepatitis reduce cirrhosis and hepatocellular carcinoma. J Hepatol 46 (2007) 45-52
9. Lau G.K. Does treatment with interferon-based therapy improve the natural history of chronic hepatitis B infection?. J Hepatol 46 (2007) 6-8
10. Sun H.C., Tang Z.Y., Wang L., Qin L.X., Ma Z.C., Ye Q.H., et al. Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial. J Cancer Res Clin Oncol 132 (2006) 458-465
11. Lo C.M., Liu C.L., Chan S.C., Lam C.M., Poon R.T., Ng I.O., et al. A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. Ann Surg 245 (2007) 831-842
12. Kubo S., Tanaka H., Takemura S., Yamamoto S., Hai S., Ichikawa T., et al. Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus. Hepatol Res 37 (2007) 94-100
13. Yu M.W., Yeh S.H., Chen P.J., Liaw Y.F., Lin C.L., Liu C.J., et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst 97 (2005) 265-272
14. Ohkubo K., Kato Y., Ichikawa T., Kajiya Y., Takeda Y., Higashi S., et al. Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma. Cancer 94 (2002) 2663-2668